Home > Healthcare > Medical Devices > Therapeutic Devices > Lung Stent Market

Lung Stent Market Size

  • Report ID: GMI4873
  • Published Date: Jun 2023
  • Report Format: PDF

Lung Stent Market Size

Lung Stent Market size was valued at over USD 165 million in 2022 and is poised to record over 11.5% CAGR from 2023 to 2032, owing to the high prevalence of COPD (chronic obstructive pulmonary disease) and post-tuberculosis stenosis globally.

 

COPD, a prominent cause of morbidity and death, frequently results in significant airway blockage. For instance, a 2022 report from CDC estimates that more than 150,000 Americans die from COPD every year. It has also been reported that over 90% of COPD fatalities occurred in middle- and low-income countries, and there is currently no cure for the condition. Lung stents offer less invasive remedies by preserving airway patency and enhancing airflow, which reduces symptoms and enhances the quality of life for patients. As a result, the growing patient base will drive up the product demand, further contributing to the market expansion.

 

However, the industry expansion may be hampered to some extent by the influx of stringent compliances and series of time-consuming tests that are required to get authorization for selling the lung stents. Additionally, gadgets categorized as Class II devices pose minimal risk to the general public's health and moderate risks to the individual users. Therefore, during the analysis timeframe, these factors may have an impact on the market progression.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Lung stent industry size was more than USD 165 million in 2022 and is estimated to grow at over 11.5% CAGR from 2023 to 2032 driven by the increasing prevalence of COPD and post-tuberculosis stenosis globally.

The tracheal product segment held 69% of the lung stents market revenue share in 2022 and is expected to grow at robust pace through 2032 owing to the decreased risk of surgical complications.

North America lung stent industry generated over USD 72.9 million in 2022 and is anticipated to grow at robust pace through 2032 driven by the rise in hospitalizations for respiratory disorders.

Some of the key lung stent firms include Merit Medical Systems, Inc., Boston Scientific Corporation, Micro-Tech (Nanjing) Co., Ltd., Hood Laboratories, Cook Group, Taewoong Medical Co Ltd, and Novatech SA, among others.

Lung Stent Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 821
  • Countries covered: 30
  • Pages: 250
 Download Free Sample